Lineus Medical Receives Japanese Patent for SafeBreak® Vascular and United States Patent for BVAD
The Californer/10206429

FAYETTEVILLE, Ark. - Californer -- Lineus Medical continues to expand its patent portfolio with the issuance of two new patents. The first issued patent was a Japanese Utility Patent (JP7095097) for SafeBreak® Vascular, a break-away medical device that helps protect peripheral IV lines. The second issued patent was a US utility patent for a dual lumen peripheral IV catheter, BVAD (Bifurcated Venous Access Device). Lineus Medical's patent portfolio has grown to nine issued patents from various countries across the world, with more patents pending.

SafeBreak Vascular is a first of its kind, FDA cleared breakaway device designed to remove harmful forces from peripheral IV (PIV) lines by intentionally separating when damaging levels of force are applied to the IV line. By preventing harmful IV line tension from reaching the catheter, SafeBreak Vascular reduces mechanical PIV complications requiring an IV restart.

More on The Californer

• California: Governor Newsom declares states of emergency related to multiple severe weather events in 2025
• California: Governor Newsom deploys dedicated teams to fight crime in Stockton, building on existing successful partnerships
• BanksyLee.com Is Redefining Daily Financial Insight for the Modern Investor
• California: Governor and LA Rises announce new online resource to further help LA fire survivors navigate rebuilding
• California: Governor Newsom's SAFE Task Force partners with Sacramento to clear encampment

BVAD, the second device in the company's pipeline, is a dual lumen peripheral IV catheter designed to allow uncontaminated blood draws from a dedicated secondary lumen while allowing normal infusions through the primary lumen. BVAD furthers the company's goal that every patient should have one catheter and one needlestick per hospitalization, and intends to provide value and efficiency to nurses and hospitals.

Vance Clement, CEO of Lineus Medical, said, "The issuance of both the Japanese patent for SafeBreak Vascular and our US patent for BVAD are significant milestones as we expand our patent portfolio and look to expand internationally. These patents are critical steps in our mission to remove the pains associated with medical lines, not just in the US, but globally."

Spencer Jones, Founder and Chief Technology Officer, commented, "Japan is the second largest medical device market in the world, so securing patent protection for SafeBreak Vascular in this market captures enormous enterprise value for our organization. BVAD has already been granted patent protection in several international markets and obtaining a patent in the US is another invaluable addition to our portfolio. Consistent innovation is crucial for emerging companies like Lineus Medical, and protecting those ideas is paramount."

More on The Californer

• Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
• Prop 1 brings new projects creating hundreds of housing units for Californians, including veterans
• Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
• Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
• Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of vascular access products that are designed to improve the patient experience, make nurse's jobs easier and lower the overall cost of healthcare. Learn more at www.lineusmed.com and follow us on LinkedIn,  Twitter, or Instagram. BVAD is not 510(k) cleared and not yet for sale.